The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The distal fallopian tube: a new model for pelvic serous carcinogenesis
Abstract
PURPOSE OF REVIEW: Research over the past 50 years has yielded little concrete information on the source of pelvic serous cancer in women, creating a knowledge gap that has adversely influenced our ability to identify, remove or prevent the earliest stages of the most lethal form of ovarian cancer. RECENT FINDINGS: The distal fallopian tube is emerging as an established source of many early serous carcinomas in women with BRCA mutations (BRCA+). Protocols examining the fimbrial (SEE-FIM) end have revealed a noninvasive but potentially lethal form of tubal carcinoma, designated tubal intraepithelial carcinoma. Tubal intraepithelial carcinoma is present in many women with presumed ovarian or peritoneal serous cancer. A candidate precursor to tubal intraepithelial carcinoma, entitled the 'p53 signature', suggests that molecular events associated with serous cancer (p53 mutations) may be detected in benign mucosa. SUMMARY: A fully characterized precursor lesion is a first and necessary step to pelvic serous cancer prevention. The emerging data offer compelling evidence for a model of 'fimbrial-ovarian' serous neoplasia, and call attention to the distal fallopian tube as an important source for this disease, the study of which could clarify pathways to cancer in both organs and generate novel strategies for cancer prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318787 · Cited by 986
Medeiros, F., Muto, M. G., Lee, Y., Elvin, J. A., Callahan, M. J., Feltmate, C., Garber, J. E., Cramer, D. W., & Crum, C. P. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180854.28831.77 · Cited by 916
Self-citationA candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 898
Self-citationDinulescu, D. M., Ince, T. A., Quade, B. J., Shafer, S. A., Crowley, D., & Jacks, T. (2005) · Nature Medicine · doi:10.1038/nm1173 · Cited by 604
Self-citationSinger, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.-F., Wang, T.-L., Kurman, R. J., & Shih, I.-M. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146025.91953.8d · Cited by 408
Finch, A., Shaw, P., Rosen, B., Murphy, J., Narod, S. A., & Colgan, T. J. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.06.065 · Cited by 375
Powell, C. B., Kenley, E., Chen, L.-M., Crawford, B., McLennan, J., Zaloudek, C., Komaromy, M., Beattie, M., & Ziegler, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.109 · Cited by 372
Salazar, H., Godwin, A. K., Daly, M. B., Laub, P. B., Hogan, W. M., Rosenblum, N., Boente, M. P., Lynch, H. T., & Hamilton, T. C. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.24.1810 · Cited by 264
Whittemore, A. S., Harris, R., & ltnyre, J. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116429 · Cited by 264
Dubeau, L. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1998.5275 · Cited by 262
Fredrickson, T. N. (1987) · Environmental Health Perspectives · doi:10.1289/ehp.877335 · Cited by 232
A Genetic Epidemiological Study of Carcinoma of the Fallopian Tube
Aziz, S., Kuperstein, G., Rosen, B., Cole, D., Nedelcu, R., McLaughlin, J., & Narod, S. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6095 · Cited by 222
Fallopian Tube and Primary Peritoneal Carcinomas Associated With BRCA Mutations
Levine, D. A., Argenta, P. A., Yee, C. J., Marshall, D. S., Olvera, N., Bogomolniy, F., Rahaman, J. A., Robson, M. E., Offit, K., Barakat, R. R., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.131 · Cited by 206
Molecular Evidence Linking Primary Cancer of the Fallopian Tube to BRCA1 Germline Mutations
Zweemer, R. P., van Diest, P. J., Verheijen, R. H. M., Ryan, A., Gille, J. J. P., Sijmons, R. H., Jacobs, I. J., Menko, F. H., & Kenemans, P. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5623 · Cited by 191
Plante, M., Rubin, S. C., Wong, G. Y., Federici, M. G., Finstad, C. L., & Gastl, G. A. (1994) · Cancer · doi:10.1002/1097-0142(19940401)73:7<1859::aid-cncr2820730714>3.0.co;2-l · Cited by 177
Schubert, E. L., Lee, M. K., Mefford, H. C., ARGONZA, R. H., Morrow, J. E., Hull, J., Dann, J. L., & King, M. (1997) · PubMed · Cited by 166
BRCA-Mutation–Associated Fallopian Tube Carcinoma: A Distinct Clinical Phenotype?
Cass, I., Holschneider, C., Datta, N., Barbuto, D., Walts, A. E., & Karlan, B. Y. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187892.78392.3f · Cited by 166
Lee, Y., Medeiros, F., Kindelberger, D. W., Callahan, M. J., Muto, M. G., & Crum, C. P. (2006) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000201826.46978.e5 · Cited by 162
Self-citationIntraperitoneal serous adenocarcinoma: A critical appraisal of three hypotheses on its cause
Piek, J. M. J., Kenemans, P., & Verheijen, R. H. M. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.02.067 · Cited by 129
Animal models of ovarian cancer
Vanderhyden, B. C., Shaw, T. J., & Éthier, J.-F. (2003) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-1-67 · Cited by 128
Werness, B. A., Afify, A. M., Bielat, K. L., Eltabbakh, G. H., Piver, M. S., & Paterson, J. M. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90269-1 · Cited by 113
Alvarado‐Cabrero, I., Navani, S. S., Young, R. H., & Scully, R. E. (1997) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199707000-00001 · Cited by 106
Age-specific ovarian cancer incidence rate patterns in the United States
Quirk, J. T., Natarajan, N., & Mettlin, C. J. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.06.052 · Cited by 78
Drapkin, R., Crum, C. P., & Hecht, J. L. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.04.014 · Cited by 70
Self-citationCasey, M. J., Bewtra, C., Hoehne, L. L., Tatpati, A. D., Lynch, H. T., & Watson, P. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5861 · Cited by 61
Ovarian Epithelial Dysplasia in Relation to Ovulation Induction and Nulliparity
Nieto, J. J., Crow, J. C., Sundaresan, M., Constantinovici, N., Perrett, C. W., MacLean, A., & Hardiman, P. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6227 · Cited by 38
Current issues in the pathology of ovarian cancer.
Rabban, J. T., & Bell, D. A. (2005) · PubMed · Cited by 22
(2000) · doi:10.1002/1097-0142(20000715)89:2
Cited by
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ahmed, A. A., Etemadmoghadam, D., Temple, J., Lynch, A. G., Riad, M., Sharma, R., Stewart, C., Fereday, S., Caldas, C., deFazio, A., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2696 · Cited by 787
Cho, K. R., & Shih, I.-M. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092246 · Cited by 694
Cancer of the ovary, fallopian tube, and peritoneum: 2021 update
Berek, J. S., Renz, M., Kehoe, S., Kumar, L., & Friedlander, M. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13878 · Cited by 514
Kurman, R. J., & Shih, I.-M. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e318161e4f5 · Cited by 460
New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
Levanon, K., Crum, C., & Drapkin, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1107 · Cited by 412
Self-citation
Metadata
- Authors
- Crum, C. P., Drapkin, R., Miron, A., Ince, T. A., Muto, M., Kindelberger, D. W., & Lee, Y.
- Venue
- Current Opinion in Obstetrics & Gynecology
- Published
- 2007-02
- Volume
- 19
- Issue
- 1
- Pages
- 3-9
- ISSN
- 1040-872X (ISSN-L)
- OpenAlex
- W2054785621
- Cited by
- 512
- References
- 29
- FWCI
- 27.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.